Extrait

Clinical first-in-human dose escalation study evaluating the safety and tolerability of intranodal administration of an RNA-based cancer vaccine targeting two tumor-associated antigens in patients with advanced melanoma

Critère d'inclusion

• Melanoma

Liens

• ictrp
• nct